Uni.-Prof. Dr. Friedemann Johannes Weber
|
ORCID: https://orcid.org/0000-0001-9737-337X Researcher ID: AAB-3425-2019 |
Projects as principal investigator
1 of 4
- SARS-CoV-2 und das antivirale Inferonsystem
01/07/2021 - 31/12/2021
Federal Ministry of Research, Technology and Space, former: Federal Ministry of Education and Research (BMFTR, BMBF) - RAPID II - Innate Immunity-Phänotyp von Viren
01/10/2020 - 30/09/2021
Federal Ministry of Research, Technology and Space, former: Federal Ministry of Education and Research (BMFTR, BMBF) - MAD-CoV2 - Modern approaches for developing antivirals against SARS-CoV 2
01/08/2020 - 31/07/2024
European Union (EU) - OPENCORONA - Rapid therapy development through Open nCoronavirus Vaccine Platform
01/04/2020 - 31/03/2022
European Union (EU) - KFO 309 TP - Virus-induced Lung Injury: Pathobiology and Novel Therapeutic Strategies - Teilprojekt: Systematische Analyse der anti-viralen Aktivität des Pathogen-Erkennungs-Rezeptors RIG-I in der Influenza Virus Infektion: Neue Zielstrukturen für antivirale Interventionsstrategien
01/03/2020 - 28/02/2023
German Research Foundation (DFG)
Projects as co-investigator or project member
- GRK 2355/2 - Regulatory networks in the mRNA life cycle: from coding to non-coding RNAs
01/01/2023 - 30/06/2027
German Research Foundation (DFG) - KFO 309/2 - Virus-induced Lung Injury: Pathobiology and Novel Therapeutic Strategies
01/01/2020 - 30/06/2024
German Research Foundation (DFG) - GRK 2355/1 - Regulatory networks in the mRNA life cycle: from coding to non-coding RNAs
01/07/2018 - 31/12/2022
German Research Foundation (DFG) - KFO 309/1 - Virus-induced Lung Injury: Pathobiology and Novel Therapeutic Strategies
01/11/2016 - 30/06/2020
German Research Foundation (DFG)
Publications
2 of 13
- Identification of Single Amino Acid Changes in the Rift Valley Fever Virus Polymerase Core Domain Contributing to Virus Attenuation In Vivo (2022)
- Frontiers in Cellular and Infection MicrobiologyCurrent Opinion in Immunology
Journal article - Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target (
- eLife
Journal article - Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response (2022)
- PNAS Nexus
Journal article - Shielding the mRNA-translation factor eIF2B from inhibitory p-eIF2 as a viral strategy to evade protein kinase R-mediated innate immunity (2022)
Journal article - Signaling mediated and signaling independent activities of the pathogen recognition receptor RIG-I during murine Influenza infection (2022)
- European Journal of ImmunologyViruses
Meeting Abstract - Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis (2022)
Journal article - The International Virus Bioinformatics Meeting 2022 (2022)
- Viruses
Journal article - What goes around comes around: Artificial circular RNAs bypass cellular antiviral responses (2022)
- Molecular Therapy: Nucleic Acids
Journal article - A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model (2021)
- Nature Microbiology
Journal article - Das neue Coronavirus SARS-CoV-2 (2021)
- Tiermedizin in Gießen
Journal article - eIF2B-capturing viral protein NSs suppresses the integrated stress response (2021)
- Nature CommunicationsPLoS Pathogens
Journal article - Identification and characterization of short leader and trailer RNAs synthesized by the Ebola virus RNA polymerase (2021)
Journal article - Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies (2021)
- Science Advances
Journal article - Imaging of SARS-CoV-2 infected Vero E6 cells by helium ion microscopy (2021)
- Beilstein Journal of NanotechnologyJournal of General Virology
Journal article - NSs of the mildly virulent sandfly fever Sicilian virus is unable to inhibit interferon signaling and upregulation of interferon-stimulated genes (2021)
Journal article
